Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to infect cells depending on environmental conditions, according to a ...

Influenza A virus particle can strategically adapt their shape, becoming either spheres or filaments, to favor their ability ...

In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...

Low vaccination rates may be contributing to the spread of flu, but data suggests the number of cases so far this season is ...

Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused about its prospects in 2025.

But if it seems as if everyone you know has gotten sick this winter (or still is), you’re not wrong: It’s been a tough season ...